US Stock MarketDetailed Quotes
BLCO Bausch + Lomb Corp.
Watchlist
15.450
+0.040+0.26% Close 12/01 16:00 ET
15.4500.0000.00%
Post 16:00 ET
15.575High15.365Low398.59KVolume
15.410Open15.410Pre Close6.17MTurnover1.00%Turnover RatioLossP/E (TTM)5.42BMarket Cap21.95052wk High908.82P/E (Static)350.86MShares14.37052wk Low0.80P/B616.95MFloat Cap21.950Historical High--Dividend TTM39.93MShs Float12.200Historical Low--Div YieldTTM1.36%Amplitude15.468Avg Price1Lot Size
Bausch + Lomb Corp. Stock Forum
Sign in to post a comment
1
ColumnsUS Top Rating Updates on 9/12: ADBE, OXY, RBLX, UNP and More
Upgrades
• $Argo Group International(ARGO.US$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache(APA.US$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway(CNI.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway(CP.US$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology(CRS.US$ : Cowen Upgra...
• $Argo Group International(ARGO.US$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache(APA.US$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway(CNI.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway(CP.US$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology(CRS.US$ : Cowen Upgra...
7
1
ColumnsUS Top Rating Updates on 9/9: MMM, REGN, ENPH, PSNY and More
Upgrades
• $Argo Group International(ARGO.US$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache(APA.US$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway(CNI.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway(CP.US$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology(CRS.US$ : Cowen Upgr...
• $Argo Group International(ARGO.US$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache(APA.US$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway(CNI.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway(CP.US$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology(CRS.US$ : Cowen Upgr...
12
2
ColumnsTop upgrades and downgrades on 7/26: UBS, ROKU, PARA, CHWY and more
Upgrades
• $Zymergen(ZY.US$ : JPMorgan Upgrades to Neutral from Underweight
Downgrades
• $Chewy(CHWY.US$: Wedbush Downgrades to Neutral from Outperform - PT $44 (from $35)
• $Paramount Global-B(PARA.US$: Goldman Sachs Downgrades to Sell from Buy - PT $20 (from $37)
• $Roku Inc(ROKU.US$: Wolfe Research Downgrades to Underperform from Peerperform - PT $77
• $UBS Group(UBS.US$: BofA Securities Downgrades to Neutral from Buy - P...
• $Zymergen(ZY.US$ : JPMorgan Upgrades to Neutral from Underweight
Downgrades
• $Chewy(CHWY.US$: Wedbush Downgrades to Neutral from Outperform - PT $44 (from $35)
• $Paramount Global-B(PARA.US$: Goldman Sachs Downgrades to Sell from Buy - PT $20 (from $37)
• $Roku Inc(ROKU.US$: Wolfe Research Downgrades to Underperform from Peerperform - PT $77
• $UBS Group(UBS.US$: BofA Securities Downgrades to Neutral from Buy - P...
16
1
How does your family feel about your trading? 
There is no objection, nor complete approval, only a golden sentence: be careful in everything, don't invest too much, pay attention to investment.Does your family support you in trading?
Support, but of course there is persuasion not to invest too much money, learn from experience first. If they do, in what ways? How did that help you?
Because my father also invested, due to the difference in the number of shares traded in each lot of US s... 7
4
ColumnsTop upgrades and downgrades on 6/24: CLR, MRO, SGEN, FUL and more
Upgrades
• $American Water Works(AWK.US$ : Janney Upgrades to Buy from Neutral
• $Becton Dickinson & Co(BDX.US$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $275
• $Altria(MO.US$ : Morgan Stanley Upgrades to Equalweight from Underweight - PT $43 (from $47)
• $Middlesex Water(MSEX.US$ : Janney Upgrades to Buy from Neutral
• $Indonesia Energy(INDO.US$ : Noble Capital Upgrades to Outperform from Market Perform - PT...
• $American Water Works(AWK.US$ : Janney Upgrades to Buy from Neutral
• $Becton Dickinson & Co(BDX.US$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $275
• $Altria(MO.US$ : Morgan Stanley Upgrades to Equalweight from Underweight - PT $43 (from $47)
• $Middlesex Water(MSEX.US$ : Janney Upgrades to Buy from Neutral
• $Indonesia Energy(INDO.US$ : Noble Capital Upgrades to Outperform from Market Perform - PT...
23
2
ColumnsTop upgrades and downgrades on 6/6
Upgrades
• $Ardagh Metal(AMBP.US$ : Barclays Upgrades to Overweight from Equalweight - PT $9
• $American Express(AXP.US$ : Edward Jones Upgrades to Buy from Hold
• $CrowdStrike(CRWD.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $215 (from $195)
• $Lululemon Athletica(LULU.US$ : Bernstein Upgrades to Market Perform from Underperform - PT $300 (from $260)
• $ResMed(RMD.US$ : RBC Upgrades to Outperform from Sector Perform - PT $244 (from $...
• $Ardagh Metal(AMBP.US$ : Barclays Upgrades to Overweight from Equalweight - PT $9
• $American Express(AXP.US$ : Edward Jones Upgrades to Buy from Hold
• $CrowdStrike(CRWD.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $215 (from $195)
• $Lululemon Athletica(LULU.US$ : Bernstein Upgrades to Market Perform from Underperform - PT $300 (from $260)
• $ResMed(RMD.US$ : RBC Upgrades to Outperform from Sector Perform - PT $244 (from $...
12
ColumnsAnalysts' screen on BLCO, SNAP, TSLA, ZM and more
GOLDMAN SACHS
•$Bausch + Lomb Corp.(BLCO.US$ Goldman Sachs analyst Amit Hazan initiated coverage of Bausch + Lomb with a Neutral rating and $22 price target, implying 22% upside potential. The analyst sees Bausch + Lomb's current offering and pipeline as positioning it well to maintain or expand share in the "attractive and durable' eye care market.
•$Steel Dynamics(STLD.US$ Goldman Sachs analyst Emily Chieng downgraded Steel Dynamics to Neutral...
•$Bausch + Lomb Corp.(BLCO.US$ Goldman Sachs analyst Amit Hazan initiated coverage of Bausch + Lomb with a Neutral rating and $22 price target, implying 22% upside potential. The analyst sees Bausch + Lomb's current offering and pipeline as positioning it well to maintain or expand share in the "attractive and durable' eye care market.
•$Steel Dynamics(STLD.US$ Goldman Sachs analyst Emily Chieng downgraded Steel Dynamics to Neutral...
21
ColumnsTop upgrades and downgrades on 5/31
Upgrades
• $Grab Holdings(GRAB.US$: Bernstein Upgrades to Outperform from Market Perform - PT $3.04
• $Linde(LIN.US$: Evercore ISI Upgrades to Outperform from In Line - PT $355
• $Magellan Midstream(MMP.US$: Wells Fargo Upgrades to Overweight from EqualWeight - PT $56 (from $54)
• $Mercury Systems(MRCY.US$: Baird Upgrades to Outperform from Neutral - PT $72 (from $56)
• $Nurix Therapeutics(NRIX.US$: Wells Fargo Upgrades to Overweight from EqualWeight - PT...
• $Grab Holdings(GRAB.US$: Bernstein Upgrades to Outperform from Market Perform - PT $3.04
• $Linde(LIN.US$: Evercore ISI Upgrades to Outperform from In Line - PT $355
• $Magellan Midstream(MMP.US$: Wells Fargo Upgrades to Overweight from EqualWeight - PT $56 (from $54)
• $Mercury Systems(MRCY.US$: Baird Upgrades to Outperform from Neutral - PT $72 (from $56)
• $Nurix Therapeutics(NRIX.US$: Wells Fargo Upgrades to Overweight from EqualWeight - PT...
16
2
ColumnsTop upgrades and downgrades on 5/11
Upgrades
• $Arcturus Therapeutics(ARCT.US$ : Baird Upgrades to Neutral from Underperform - PT $18 (from $21)
• $Arrowhead Pharmaceuticals(ARWR.US$ : Baird Upgrades to Outperform from Neutral - PT $60 (from $71)
• $Cronos Group(CRON.US$ : CIBC Upgrades to Outperformer from Neutral
• $HF Sinclair Corp(DINO.US$ : Cowen Upgrades to Outperform from Market Perform - PT $52 (from $38)
• $8x8(EGHT.US$ : B. Riley Upgrades to Buy from Neutral - PT $13.50
• $Novanta(NOVT.US$ : William...
• $Arcturus Therapeutics(ARCT.US$ : Baird Upgrades to Neutral from Underperform - PT $18 (from $21)
• $Arrowhead Pharmaceuticals(ARWR.US$ : Baird Upgrades to Outperform from Neutral - PT $60 (from $71)
• $Cronos Group(CRON.US$ : CIBC Upgrades to Outperformer from Neutral
• $HF Sinclair Corp(DINO.US$ : Cowen Upgrades to Outperform from Market Perform - PT $52 (from $38)
• $8x8(EGHT.US$ : B. Riley Upgrades to Buy from Neutral - PT $13.50
• $Novanta(NOVT.US$ : William...
15
No comment yet
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
MettOP : Took half off at 1R